SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,519.41 |
| Enterprise Value ($M) | 2,494.25 |
| Book Value ($M) | 552.36 |
| Book Value / Share | 8.23 |
| Price / Book | 4.56 |
| NCAV ($M) | 551.89 |
| NCAV / Share | 8.23 |
| Price / NCAV | 4.57 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 47.57 |
| Current Ratio | 47.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 563.86 |
| Assets | 564.33 |
| Liabilities | 11.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.20 |
| Operating Income | -55.45 |
| Net Income | -48.61 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -45.68 |
| Cash from Investing | -121.19 |
| Cash from Financing | 87.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Unique Diamond Investments Ltd | 8.30 | ||
| 13G/A | Decheng Capital Global Life Sciences Fund IV, L.P. | 8.20 | 7.91 | |
| 13G | Kissei Pharmaceutical Co., Ltd. | 5.30 | ||
| 13G | TCG Crossover GP I, LLC | 5.40 | ||
| 13G | Longitude Capital Partners IV, LLC | 7.00 | ||
| 13G | Foresite Capital Fund V, L.P. | 5.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 122,262 | 752,883 | 16.24 | |
| 54,550 | 391,722 | 13.93 | |
| 58,032 | 335,993 | 17.27 | |
| 48,793 | 314,328 | 15.52 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CCCC – C4 Therapeutics, Inc. | CGC – Canopy Growth Corporation |
| CGEM – Cullinan Therapeutics, Inc. | COGT – Cogent Biosciences, Inc. |
| COLL – Collegium Pharmaceutical, Inc. |
Financial data and stock pages provided by
Fintel.io